Published Date: 29 Jan 2024
CAR T-cell therapies still have a significant potential benefit to risk ratio.
Read Full NewsOcular motor cranial neuropathy is associated with an increased risk for Parkinson’s disease, a new study shows.
Traumatic brain injury is bidirectionally associated with the incidence of stroke, dementia, epilepsy, and Parkinson’s disease, a retrospective study shows.
A large database study found overall 5- and 10-year improvement in pediatric cancer survival, but some cancers lag others, and demographic factors seem to influence trends.
Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.
A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.
All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.
Emerging evidence suggests coffee influences gut microbiota through bioactive compounds beyond caffeine, with potential effects on digestive and metabolic health.
1.
Study confirms link between breast density, higher breast cancer risk
2.
After all, Pulled Myeloma Drug May Help Treat the Illness.
3.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
1.
Progressive Insights in Hematology in the Digital Era
2.
Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options
3.
Modern Updates in Hematology in the Digital Era
4.
Revolutionizing Cancer Care with Fulphila: A New Hope for Patients
5.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation